Cargando…

Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India

BACKGROUND AND OBJECTIVES: Although a relatively recent concept for developing countries, the developed world has been using League Tables as a policy guiding tool for a comprehensive assessment of health expenditures; country-specific “League tables” can be a very useful tool for national healthcar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Komal, Singh, Malkeet, Kotwani, Priya, Tyagi, Kirti, Pandya, Apurvakumar, Saha, Somen, Saxena, Deepak, Rajshekar, Kavitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606776/
https://www.ncbi.nlm.nih.gov/pubmed/36311623
http://dx.doi.org/10.3389/fpubh.2022.831254
_version_ 1784818373589204992
author Shah, Komal
Singh, Malkeet
Kotwani, Priya
Tyagi, Kirti
Pandya, Apurvakumar
Saha, Somen
Saxena, Deepak
Rajshekar, Kavitha
author_facet Shah, Komal
Singh, Malkeet
Kotwani, Priya
Tyagi, Kirti
Pandya, Apurvakumar
Saha, Somen
Saxena, Deepak
Rajshekar, Kavitha
author_sort Shah, Komal
collection PubMed
description BACKGROUND AND OBJECTIVES: Although a relatively recent concept for developing countries, the developed world has been using League Tables as a policy guiding tool for a comprehensive assessment of health expenditures; country-specific “League tables” can be a very useful tool for national healthcare planning and budgeting. Presented herewith is a comprehensive league table of cost per Quality Adjusted Life Years (QALY) or Disability Adjusted Life Years (DALY) ratios derived from Health Technology Assessment (HTA) or economic evaluation studies reported from India through a systematic review. METHODS: Economic evaluations and HTAs published from January 2003 to October 2019 were searched from various databases. We only included the studies reporting common outcomes (QALY/DALY) and methodology to increase the generalizability of league table findings. To opt for a uniform criterion, a reference case approach developed by Health Technology Assessment in India (HTAIn) was used for the reporting of the incremental cost-effectiveness ratio. However, as, most of the articles expressed the outcome as DALY, both (QALY and DALY) were used as outcome indicators for this review. RESULTS: After the initial screening of 9,823 articles, 79 articles meeting the inclusion criteria were selected for the League table preparation. The spectrum of intervention was dominated by innovations for infectious diseases (33%), closely followed by maternal and child health (29%), and non-communicable diseases (20%). The remaining 18% of the interventions were on other groups of health issues, such as injuries, snake bites, and epilepsy. Most of the interventions (70%) reported DALY as an outcome indicator, and the rest (30%) reported QALY. Outcome and cost were discounted at the rate of 3 by 73% of the studies, at 5 by 4% of the studies, whereas 23% of the studies did not discount it. Budget impact and sensitivity analysis were reported by 18 and 73% of the studies, respectively. INTERPRETATION AND CONCLUSIONS: The present review offers a reasonably coherent league table that reflects ICER values of a range of health conditions in India. It presents an update for decision-makers for making decisions about resource allocation.
format Online
Article
Text
id pubmed-9606776
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96067762022-10-28 Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India Shah, Komal Singh, Malkeet Kotwani, Priya Tyagi, Kirti Pandya, Apurvakumar Saha, Somen Saxena, Deepak Rajshekar, Kavitha Front Public Health Public Health BACKGROUND AND OBJECTIVES: Although a relatively recent concept for developing countries, the developed world has been using League Tables as a policy guiding tool for a comprehensive assessment of health expenditures; country-specific “League tables” can be a very useful tool for national healthcare planning and budgeting. Presented herewith is a comprehensive league table of cost per Quality Adjusted Life Years (QALY) or Disability Adjusted Life Years (DALY) ratios derived from Health Technology Assessment (HTA) or economic evaluation studies reported from India through a systematic review. METHODS: Economic evaluations and HTAs published from January 2003 to October 2019 were searched from various databases. We only included the studies reporting common outcomes (QALY/DALY) and methodology to increase the generalizability of league table findings. To opt for a uniform criterion, a reference case approach developed by Health Technology Assessment in India (HTAIn) was used for the reporting of the incremental cost-effectiveness ratio. However, as, most of the articles expressed the outcome as DALY, both (QALY and DALY) were used as outcome indicators for this review. RESULTS: After the initial screening of 9,823 articles, 79 articles meeting the inclusion criteria were selected for the League table preparation. The spectrum of intervention was dominated by innovations for infectious diseases (33%), closely followed by maternal and child health (29%), and non-communicable diseases (20%). The remaining 18% of the interventions were on other groups of health issues, such as injuries, snake bites, and epilepsy. Most of the interventions (70%) reported DALY as an outcome indicator, and the rest (30%) reported QALY. Outcome and cost were discounted at the rate of 3 by 73% of the studies, at 5 by 4% of the studies, whereas 23% of the studies did not discount it. Budget impact and sensitivity analysis were reported by 18 and 73% of the studies, respectively. INTERPRETATION AND CONCLUSIONS: The present review offers a reasonably coherent league table that reflects ICER values of a range of health conditions in India. It presents an update for decision-makers for making decisions about resource allocation. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606776/ /pubmed/36311623 http://dx.doi.org/10.3389/fpubh.2022.831254 Text en Copyright © 2022 Shah, Singh, Kotwani, Tyagi, Pandya, Saha, Saxena and Rajshekar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Shah, Komal
Singh, Malkeet
Kotwani, Priya
Tyagi, Kirti
Pandya, Apurvakumar
Saha, Somen
Saxena, Deepak
Rajshekar, Kavitha
Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title_full Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title_fullStr Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title_full_unstemmed Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title_short Comprehensive league table of cost-utility ratios: A systematic review of cost-effectiveness evidence for health policy decisions in India
title_sort comprehensive league table of cost-utility ratios: a systematic review of cost-effectiveness evidence for health policy decisions in india
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606776/
https://www.ncbi.nlm.nih.gov/pubmed/36311623
http://dx.doi.org/10.3389/fpubh.2022.831254
work_keys_str_mv AT shahkomal comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT singhmalkeet comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT kotwanipriya comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT tyagikirti comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT pandyaapurvakumar comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT sahasomen comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT saxenadeepak comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia
AT rajshekarkavitha comprehensiveleaguetableofcostutilityratiosasystematicreviewofcosteffectivenessevidenceforhealthpolicydecisionsinindia